Search | IOVS | ARVO Journals

Showing 1 – 20 of 44

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Incidence of Cataract in Eyes with Anterior Uveitis

John H Kempen; George N. Papaliodis; Bernard Rosner; Kurt Dreger; Gui-Shuang Ying; C Stephen Foster; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2069. doi:

ARVO Annual Meeting Abstract June 2020

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Caroline Minkus; Maxwell Pistilli; Kurt Dreger; Tonetta Fitzgerald; Abhishek Payal; Hosne Begum; R Oktay Kacmaz; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt; C Stephen Foster; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2070. doi:

ARVO Annual Meeting Abstract June 2020

Hierarchical Cluster Analysis of Serum and Vitreous Cytokines in Intermediate, Posterior and Panuveitis

David Dao; Sonny Caplash; Sapna Gangaputra; pradeep dagur; Susan Vitale; Douglas A Jabs; MUST Research Group; J. Philip McCoy; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3655. doi:

ARVO Annual Meeting Abstract July 2019

Birdshot Chorioretinitis: Treatment & Remission Outcomes

Eric L Crowell; Richard France; Palak Majmudar; Douglas A Jabs; Jennifer E Thorne

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3506. doi:

ARVO Annual Meeting Abstract July 2019

Oscillatory Potentials in Patients with Posterior Uveitis

Scott E Brodie; Naomi Goldberg; Alan Friedman; Douglas A Jabs; Diane Wang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5949. doi:

ARVO Annual Meeting Abstract July 2019

Factors Predictive of Remission of Chronic Anterior Uveitis

Lucia Sobrin; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; Pichaporn Artornsombudh; Siddharth Pujari; Charles Stephen Foster; Douglas A Jabs; James T Rosenbaum; Grace Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6683. doi:

ARVO Annual Meeting Abstract July 2019

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

John H Kempen; Craig W Newcomb; Charles S Foster; Douglas A Jabs; Grace Levy-Clarke; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; Jeanine M Buchanich

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3854. doi:

Retina May 2019

Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS

PDF

Douglas A. Jabs; Mark L. Van Natta; Garrett Trang; Norman Jones; Jeffrey M. Milush; Ryan Cheu; Nichole R. Klatt; Jeong Won Pak; Ronald P. Danis; Peter W. Hunt
TAGS: acquired immunodeficiency syndrome, inflammation, retinal vascular caliber, linear regression
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2218-2225. doi: https://doi.org/10.1167/iovs.18-26070

Includes: Supplemental Content

Immunology and Microbiology May 2019

Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS

PDF

Gary N. Holland; Mark L. Van Natta; David T. Goldenberg; Rory Ritts Jr; Ronald P. Danis; Douglas A. Jabs; for the Studies of Ocular Complications of AIDS Research Group
TAGS: acquired immunodeficiency syndrome, cytomegalovirus retinitis, immunologic deficiency syndromes
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):1853-1862. doi: https://doi.org/10.1167/iovs.18-26517

ARVO Annual Meeting Abstract July 2018

Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome

Douglas A Jabs; Mark L. Van Natta; Jeong W Pak; Ronald P Danis; Peter Hunt

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5564. doi:

ARVO Annual Meeting Abstract July 2018

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Elizabeth A Sugar; Janet A Holbrook; Alyce E Burke; Glenn J Jaffe; Albert T Vitale; Janet L. Davis; Douglas A Jabs

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):417. doi:

Retina February 2018

Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome

PDF

Douglas A. Jabs; Mark L. Van Natta; Jeong Won Pak; Ronald P. Danis; Peter W. Hunt
TAGS: acquired immunodeficiency syndrome, age-related macular degeneration, retinal vascular caliber, retinal vasculature
Invest. Ophthalmol. Vis. Sci.. 2018; 59(2):904-908. doi: https://doi.org/10.1167/iovs.17-23334

ARVO Annual Meeting Abstract June 2017

Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome

Douglas A Jabs; Mark L Van Natta; Ronald P Danis; Jeong Pak; Peter Hunt

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1623. doi:

ARVO Annual Meeting Abstract September 2016

Agreement among Uveitis Experts on Diagnosis: The SUN Classification Criteria Project Experience

Douglas A. Jabs

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Lessons on immune evasion in the retina by viruses secondary to AIDS

Douglas A. Jabs

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

John H Kempen; Michael M Altaweel; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3209. doi:

ARVO Annual Meeting Abstract June 2015

Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome

Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald P Danis; Studies of the Ocular Complications of AIDS Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1409. doi:

ARVO Annual Meeting Abstract June 2015

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Michael M Altaweel; John H Kempen; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5774. doi:

ARVO Annual Meeting Abstract June 2015

Relationships between HIV-related Neuroretinal Disorder and Measures of Vision-Specific Quality of Life among People with AIDS

Davin Ashraf; Kevin Patrick May; Gary N Holland; Mark L Van Natta; Albert Wu; Jennifer E Thorne; Douglas A Jabs; Studies of the Ocular Complications of AIDS (SOCA) Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5777. doi:

ARVO Annual Meeting Abstract June 2015

Dissociations of fluocinolone acetonide implants in the MUST study

Jennifer E Thorne; Elizabeth Sugar; Alyce Burke; Albert T Vitale; Douglas A Jabs; Janet T. Holbrook; Multicenter Uveitis Steroid Treatment (MUST)

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3108. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Incidence of Cataract in Eyes with Anterior Uveitis

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Hierarchical Cluster Analysis of Serum and Vitreous Cytokines in Intermediate, Posterior and Panuveitis

Birdshot Chorioretinitis: Treatment & Remission Outcomes

Oscillatory Potentials in Patients with Posterior Uveitis

Factors Predictive of Remission of Chronic Anterior Uveitis

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS

Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS

Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome

Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome

Agreement among Uveitis Experts on Diagnosis: The SUN Classification Criteria Project Experience

Lessons on immune evasion in the retina by viruses secondary to AIDS

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Relationships between HIV-related Neuroretinal Disorder and Measures of Vision-Specific Quality of Life among People with AIDS

Dissociations of fluocinolone acetonide implants in the MUST study

To View More...

You must be signed into an individual account to use this feature.